HAS

French National Authority for Health (Haute Autorité de Santé)

5, avenue du Stade de France

F-93218 Saint-Denis La Plaine Cedex

France

Email: eunethta-has@has-sante.fr

http://www.has-sante.fr/

EUnetHTA involvement

As Lead Partner

• EUnetHTA Joint Action 3 (2016-20)
  • Work Package 5 – Life cycle approach to improve Evidence Generation
• EUnetHTA Joint Action 2 (2012-15)
  • JA2 WP7 – Methodology development and evidence generation: Guidelines and pilots production
• EUnetHTA Joint Action (2010-12)
  • JA WP7 – New Technologies
• EUnetHTA Project (2006-08)
  • Project WP7 – New Technologies

As Co-lead Partner

• EUnetHTA Joint Action (2010-12)
  • JA WP5 – Relative Effectiveness Assessment of Pharmaceuticals

As Associated Partner

• EUnetHTA Joint Action 2 (2012-15)
  • JA2 WP1 – Coordination
  • JA2 WP2 – Dissemination
  • JA2 WP3 – Evaluation
  • JA2 WP4 – Testing collaborative production of HTA information for national adaptation and reporting
  • JA2 WP5 – Applying the HTA Core Model for Rapid Assessment for national adaptation and reporting
  • JA2 WP6 – Information Management Infrastructure and Services (IMIS)
  • JA2 WP7 – Methodology development and evidence generation: Guidelines and pilots production
  • JA2 WP8 – Maintenance of HTA Core Model infrastructure to support shared production and sharing of HTA information
• EUnetHTA Joint Action (2010-12)
  • JA WP1 – Coordination
  • JA WP6 – Information Management System
  • JA WP8 – Strategy and Business Model Development
• EUnetHTA Project (2006-08)
  • Project WP2 – Communications
  • Project WP1 – Coordination
  • Project WP5 – Adapting HTA
• EUnetHTA Joint Action 3 (2016-20)
  • Work Package 1 – Network Coordination
  • Work Package 2 – Dissemination
  • Work Package 3 – Evaluation
  • Work Package 7 – National implementation and impact
  • Work Package 4 – Joint Production
  • Work Package 6 – Quality Management, Scientific Guidance and Tools